Japanese encephalitis virus (JEV) is a mosquito-borne zoonotic flavivirus that causes encephalitis and reproductive disorders in mammalian species. However, key host genes involved in the JEV life cycle and cell death are poorly understood. Here, we designed 85,674 single guide RNAs (sgRNAs) targeting 17,743 protein-coding genes, 11,053 long ncRNAs (lncRNAs), and 551 microRNAs (miRNAs) in the porcine genome, and subsequently developed a porcine sgRNA library and genome-scale CRISPR/Cas9 knockout (PigGeCKO) system. These sgRNAs were delivered into porcine kidney-15 (PK-15) cells that constitutively express Cas9, positive selection screening of the resulting PigGeCKO cell collection for resistance to JEV-induced cell death led to the identification of several previously unreported genes required for JEV infection. We conducted follow-up studies to verify the dependency of JEV on these genes, and identified functional contributions for six of the many candidate JEV-related host genes, including an endoplasmic reticulum membrane protein complex subunit 3 (EMC3) and calreticulin (CALR). Additionally, we identified that four genes associated with heparan sulfate proteoglycans (HSPGs) metabolism, specifically those responsible for HSPG sulfurylation, facilitated JEV entry into PK-15 cells. Thus, beyond our development of the largest CRISPR-based functional genomic screening platform for pig research to date, this work deepens our basic understanding of flavivirus infection and identifies multiple potentially vulnerable targets for the development of medical and breeding technologies to prevent and treat diseases caused by Japanese encephalitis virus.
INTRODUCTION
Numerous viruses in nature are capable of infecting both humans and domestic animals.
Among these is Japanese encephalitis virus (JEV), a flavivirus which is closely related to Dengue Virus (DENV), Zika Virus (ZIKV), Yellow Fever Virus (YFV), West Nile Virus (WNV) and Hepatitis C Virus (HCV) 1, 2 . JEV is the leading cause of viral encephalitis in humans in some Asian countries, with an estimated 69,000 severe clinical cases and approximately 13,600 to 20,400 deaths annually 3 , despite the widespread use of vaccine.
While several inactivated and live vaccines are used to prevent JEV infection, no antiviral drugs are available for the treatment of JEV-related diseases 4, 5 . Despite achievements in control and prevention of JEV infection, this disease remains a major public health concern in Northern Oceania and in South, East, and Southeast Asia, and is viewed as an emerging global pathogen 6 .
JEV is a mosquito-borne virus that can be greatly amplified in pigs, causing swine encephalitis and reproductive complications in this species. Pigs are readily infected with JEV and can develop high levels of viremia 7, 8 . JEV infection is usually asymptomatic in adult pigs, but manifestations of abortion, still-birth, and birth defects, including central nervous system defects, are not unusual following infection in pregnant swine, which can result in substantial economic losses to pork producers 9, 10 . Accordingly, JEV outbreaks represent a major threat to both public health and the agricultural economy, especially in areas with low vaccine coverage and/or limited diagnostic capacity 11 . Currently, JEV is only endemic in the Asia-Pacific region, however it was previously shown that domesticated pigs could potentially become amplification hosts upon the introduction of JEV in other countries 12 .
The JEV infection cycle starts with binding to unknown cellular receptors and attachment factors 6, 13 , followed by viral entry to enable replication. Subsequently, the JEV RNA genome is replicated, viral particles are matured and packaged, and released from cells.
JEV infects a variety of cell types from diverse species (including mammals, birds, amphibians, and insects), suggesting that JEV can likely access multiple cell types using multiple host receptors 14 . In recent years, tremendous progress has been made in understanding the viral components required for the various steps of JEV entry and replication, but little is known about the host cell components involved in this process [15] [16] [17] [18] .
Understanding virus-host interactions by elucidating the molecular mechanisms of viral transmission can help identify potential antiviral targets for developing both prophylactic and therapeutic medicines.
Efforts to treat and prevent viral infectious have traditionally been aided by genetic screening research to improve our understanding of viral dependencies and to identify potential antiviral strategies. The emergence of CRISPR genetic screening tools has spurred a new era of efficient, versatile, and large-scale screening efforts, with notable examples for flaviviridae family viruses [19] [20] [21] . Indeed, work in human cell lines based on CRISPR-based screening strategies (with virus-induced cell death readout phenotypes) have successfully identified required host genes for infection by DENV, ZIKV, WNV, YFV, and HCV [20] [21] [22] [23] [24] . These studies have repeatedly illustrated that genome-scale CRISPR screening represents an extremely powerful tool for both basic biology and medical research. However, we are unaware of any genome-scale efforts to examine JEV infection; moreover, there are no reports of genome-scale CRISPR/Cas9 libraries for screening studies in pigs.
Aiming to develop such a resource, and specifically seeking to study the genetic basis of resistance against JEV infection, we developed a resource which we term PigGeCKO (for porcine genome-scale CRISPR knockout), which is comprised of a library of~85,000 sgRNA constructs (both as plasmids and as prepared lentiviruses). After developing this genome-scale sgRNA library, we infected JEV-susceptible porcine kidney-15 (PK-15) cells 25 stably expressing the Cas9 protein with the pooled lentiviral sgRNA library, and used Fluorescence-Activated Cell Sorting (FACS) to isolate and enrich cells harboring sgRNA constructs. We then performed positive selection screening by exposing the PigGeCKO cell collection to repeated rounds of JEV challenge, retaining the viable (i.e., JEV-resistant) cells from each round. PCR amplification and deep sequencing enabled us to detect enrichment among the candidate JEV-infection-associated genes for annotations relating to heparan sulfate proteoglycans (HSPGs) and endoplasmic reticulum-associated protein degradation (ERAD) pathways. We then generated single gene knockout cell lines for six of the candidate genes, and successfully confirmed their requirement for JEV infection of PK-15 cells. These newly discovered host genes are potential targets for the development of therapies for the treatment of Japanese encephalitis and porcine diseases caused by JEV, and can also be used in the construction of genetically edited disease-resistant animal models. We anticipate that our benchmark-setting CRISPR/Cas9 screening resources will greatly facilitate basic and applied functional genomics research in pigs.
RESULTS

Strategy for identifying genes essential for JEV-induced cell death in pigs
The overall development process of the PigGeCKO resources is depicted in the schematic diagram in Fig. 1a , and proceeded as follows. We initially used CRISPR-offinder (v1.2) 26 to design 85,674 specific and predicted high-efficiency sgRNAs, that collectively targeted 17,743 protein-coding genes, 11,053 lncRNAs, and 551 miRNAs in the porcine genome, as well as 1,000 negative control sgRNA constructs predicted not to target any porcine genome loci ( Fig. 1b , Supplementary Table 1 ). Three sgRNA constructs were designed for each targeted locus, all loci which met the selection criteria detailed in the Materials and Methods were targeted. These designed sgRNA constructs were synthesized as an oligo array, which was employed as the template for PCR amplification of the sgRNA oligos that were subsequently cloned into lentiviral vectors using Gibson assembly.
To test the quality of the PigGeCKO plasmid library, we PCR amplified the cloned sgRNA constructs, performed deep sequencing, and found that 96.2% (82,426/85,674) of the initially designed and synthesized sgRNA sequences were present in the plasmid library ( Fig. 1c , Supplementary Table 2 ). Although a small fraction of sgRNA were under-or over-represented, approximately 90% of the sgRNAs were within a range covering a tenfold difference in frequency ( Fig. 1c ). In parallel with our sgRNA library preparation, we developed a PK-15 cell line that stably expressed high levels of Cas9 (PK-15-Cas9, Clone-#14, Supplementary Fig. 1 ). We used an sgRNA lentivirus targeting the randomly selected ANPEP gene to assess the capacity of this cell line for gene editing ( Supplementary Fig. 2a ), and found that gene-editing activity tended to be stable approximately 6-10 days post-infection of the sgRNA-harboring lentivirus in PK-15-Cas9 cells ( Supplementary Fig. 2b , c).
We next generated the PigGeCKO lentivirus library by transfecting HEK293T cells with the lentiviral sgRNA plasmids together with helper plasmids. To minimize the chance of inserting multiple sgRNAs into the same PK-15-Cas9 cells, we employed a low multiplicity of infection (MOI) to obtain a transduction rate of around 30% according to a previous study 27 . The lentivirus sgRNA library was subsequently transducted into PK-15-Cas9 cells. We performed FACS-based sorting on the signal from the green fluorescent protein (GFP) reporter which was included in all PigGeCKO constructs, infected cells with the sgRNA construct sequences were PCR amplified followed by deep sequencing. Strikingly, 94.7% (81,095/85,674) of the originally designed sgRNA sequences were retained in the PigGeCKO knockout cell collection ( Fig. 1d , Supplementary Table 2 ). Furthermore, the plasmid library and PigGeCKO cell collection included all three of the designed sgRNA sequences for the majority of the targeted loci in the pig genome ( Fig. 1e ). Finally, one of the originally designed sgRNA sequences (targeting the IZUMO3 gene) was randomly selected to evaluate potential off-target effects ( Supplementary Fig. 3a ). A T7EN Ⅰ cleavage assay revealed no off-target cleavage for any of the predicted potential off-target sites ( Supplementary Fig. 3b ). Collectively, this work demonstrates the development of a highly active and specific PigGeCKO resource with high utility for functional genomics research in pigs.
JEV-induced cell death screening of the PigGeCKO cell collection to identify required host genes
We next developed a screening strategy, illustrated in Fig. 2a , to identify host genes required for successful JEV infection. To determine the optimal virus level for JEV-induced cell death in PK-15 cells for CRISPR screening, we examined JEV-induced cell death following infection at multiplicity of infection (MOI) of 0, 0.01, 0.05, and 0.1.
As the infection dose of JEV was increased, we observed cytopathic effects (CPE) at approximately days 3-4 post virus infection; phenotypes included the rounding up and enlargement of cells, the formation of syncytia, and the detachment of cells into the medium ( Supplementary Fig. 4a ). Additionally, immunofluorescence analysis enabled us to detect the expression of the JEV-encoded NS3 protein in infected PK-15 cells ( Supplementary Fig. 4b ).
Having established that PK-15 cells are a suitable model for identifying host genes with functions relating to JEV infection, we undertook our screen to identify host genes that Focusing on protein coding genes, our screen found that a total of 2,181 unique sgRNA sequences were present in at least ten cells in the third and fourth rounds of JEV challenge. Among the originally designed 52,928 sgRNAs targeting 17,743 protein-coding genes ( Supplementary Table 3 ), after JEV challenge, only 280 of the sgRNA constructs were present in at least 1,000 of the total population of analyzed cells (~0.5% of the total analyzed cells) (Supplementary Table 3 ). The top ten most enriched candidate genes after the third JEV challenge round were (highest-to-lowest) SEC63, PRKCSH, SLC35B2, RNF145, SMOX, CALR, DMGDH, EXT2, B3GAT3, and GSTO2 ( Figure 2B ); the fourth challenge round identified the same enriched genes with the exception of EXT1 for SLC35B2 ( Fig. 2c ). When taking into consideration the design of three sgRNAs constructs for each targeted locus of the porcine genome, we found that multiple sgRNAs for the SEC63, SLC35B2, and B3GAT3 genes were among the most highly enriched sequences after both the third and fourth rounds of JEV challenge (Fig.   2b , c).
After the third JEV challenge round, there were 57 sgRNA constructs present in at least 10,000 cells, and 219 sgRNA constructs present in at least 1,000 cells; after the fourth JEV challenge round, these numbers were, respectively, 57 and 239 (Supplementary Table 3 ). Comparison of enriched sgRNAs from the positive selection CRISPR screening revealed that 86.3% of the very highly enriched (i.e., ≥ 10,000) sequences were common to both the third and fourth challenge rounds and that 89.9% of the highly enriched (≥ 1,000) sequences were common to both rounds ( Fig. 2d, e ). These results highlight the capacity for CRISPR-based positive selection screening to consistently identify strong candidate genes. To explore the predicted biological functions of the candidate JEV-resistance genes, we performed KEGG pathway enrichment analyses for top 0.5% ranked sgRNA targets from the third and fourth JEV challenge rounds. These analyses revealed that the candidate JEV-resistance genes were significantly enriched for heparan sulfate proteoglycan metabolism and for Golgi and endoplasmic reticulum functions ( Fig.   2f ). Among these genes, B3GAT3 and EXT1 have known roles in JEV replication 28 . These results indicate that key host factors involved in JEV replication can be identified through multiple rounds of CRISPR screening.
Knockout of Heparan sulfate proteoglycan (HSPG) pathway related genes significantly inhibits JEV entry
There are conflicting findings from previous studies of possible functional roles for heparan sulfate pathway proteins as cellular attachment factors during initiation of JEV infection 29, 30 . HSPGs encompass a diverse class of proteins defined by the substitution with HS glycosaminoglycan (GAG) polysaccharide chains 31, 32 . Our genome-scale CRISPR screen for JEV-infection related genes indicated that 10 genes associated with HSPG metabolism were among the most highly enriched sgRNA targeted genes: EXT1, EXT2, GLCE, HS6ST1, B3GAT3, B4GALT7, XYLT7, EXTL3, SLC35B2, and GAA ( Fig.   3a ). Among these genes, SLC35B2, EXT1, and EXT2 were ranked in top 10 from both the third and fourth JEV challenge rounds. Notably, the EXT1 and HS6ST1 genes were each targeted by three separate sgRNA constructs, all of which were highly enriched, clearly indicating potential JEV-infection-related functions (Fig. 3b ). HSPG synthesis and sulfation is driven by >20 different genes 28 ; as shown in Fig. 3c and d, the significant enrichment of specific sgRNAs identified 7 genes potentially involved in HSPG synthesis and metabolic pathways, and 2 genes potentially involved in sulfurylation modifications of HSPG 33, 34 in porcine cells.
Building from these initial candidate hits, we used CRISPR/Cas9 to generate SLC35B2, HS6ST1, B3GAT3 and GLCE single knockout cell lines. Sanger sequencing confirmed that each of these monoclonal knockout cell lines had one or more nucleotide deletions predicted to cause a frameshift mutation in the coding regions of the targeted gene (a non-integer multiple of 3) ( Fig. 4a ). Viral loads in JEV-infected SLC35B2, HS6ST1, B3GAT3, and GLCE knockout cells and in wild-type PK-15 cells were measured at 18 hpi (hours post-infection) by plaque assay (Fig. 4b ). In agreement with reduced viral loads observed in knockout cells, immunofluorescence assays showed that expression of the JEV-encoded NS3 protein in all four knockout cell lines was significantly reduced or undetectable following JEV infection at both 0.03 and 0.1 MOI (Fig. 4c ). Next, cell cultures were sampled at 18 hpi for quantification of JEV genome copy number based on absolute quantitative PCR analysis using a pair of primers targeting the C gene of JEV.
These analyses revealed that knockout of these four HSPG-related genes significantly inhibited JEV replication (12 hpi) ( Fig. 4d ). Furthermore, use of an antibody against Heparin/Heparan Sulfate antibody (10E4) to conduct immunofluorescence assays revealed that knockout of the SLC35B2 and HS6ST1 genes resulted in a significant reduction in the HSPG sulfurylation level compared to wild-type cells (Fig. 4e ). This observation clearly suggests that sulfurylation modifications of HSPG can significantly and functionally impact the interaction between JEV and HSPG in PK-15 cells, potentially during viral entry. Finally, an EdU fluorescence assay showed no difference in cell proliferation rates of knockout and wide-type cells ( Supplementary Fig. 5 ).
Collectively, these results indicate that HSPG can act as a cellular adhesion factor or cofactor that mediates JEV entry.
EMC3 is required for JEV replication
The endoplasmic reticulum membrane complex (EMC) is known to be required for infection by flaviviruses, which have RNA genomes 35, 36 . However, it is unclear whether EMC family genes are involved in JEV replication. Interestingly, our genome-scale CRISPR JEV infection screen showed that EMC3 and EMC6 genes, both of which encode ER membrane protein complex subunits, were ranked 44 and 34 among the candidate hits in the fourth JEV challenge round, respectively (Supplementary Table 3 ).
As such, we generated two independent EMC3 null cell lines using CRISPR/Cas9. Sanger sequencing confirmed the presence of 1 or 2 bp deletions or insertions (a non-integer multiple of 3) in both EMC3 knockout cell lines (Fig. 5a ), and immunoblotting confirmed that the EMC3 protein was not expressed in cells of either knockout line ( Fig. 5b ).
Subsequently, viral concentrations in JEV-infected EMC3 null and wild-type PK-15 cells were determined at 0, 12, 24, and 36 hpi by both plaque assay and quantification of JEV genome copy number based on absolute quantitative PCR analysis using a pair of primers targeting the C gene of JEV. Together, these analyses revealed that knockout of the EMC3 gene significantly inhibited JEV replication (12 hpi) ( Fig. 5c, d ). Both JEV-infected EMC3 knockout cell lines possessed substantially reduced levels of viral NS3 protein expression as determined via immunofluorescence analysis ( Fig 5E) and immunoblotting ( Fig 5F) . Finally, the ability of EMC3 knockout cells to resist JEV-induced death at a high dose (MOI = 1) was evaluated. The result from cultures grown using a Real-Time Cell Analyzer (RTCA) verified that EMC3 knockout cells were able to completely resist JEV-induced cell death ( Fig. 5g ). Collectively, these results demonstrate that the EMC3 is required for JEV-induced PK-15 cell death.
CALR is required for JEV replication
Among the top 10 ranked genes in the genome-scale CRISPR screen for JEV infection screening candidates was a gene known to function in intracellular calcium homeostasis:
CALR. To explore the potential function of CALR in mediating JEV replication, CALR knockout cells was generated by CRISPR/Cas9. Sanger sequencing showed that the selected monoclonal CLAR knockout cells have a 1 bp insertion (Fig. 6a ), and immunoblotting confirmed that the CALR protein was not expressed in the knockout cells ( Fig. 6b ).
Next, plaque assays and absolute quantitative real-time PCR were used to measure viral concentrations in JEV-infected CALR null and wild-type PK-15 cells at 12 and 24 hpi.
Concurrently, JEV-infected cell cultures were harvested at 12, 18, 24, 36 and 48 hpi, and viral RNA was extracted from cell suspensions and cDNAs were synthesized as absolute quantitative PCR template. As shown in Fig. 6c and d , knockout of the CALR gene significantly inhibited JEV replication. Moreover, immunofluorescence results showed that the NS3 protein was only weakly expressed at 12, 18 and 24 hpi in JEV-infected CALR null cell lines (Fig. 6e) . Finally, the ability of CALR knockout cells to resist JEV-induced death at a high challenge dose (MOI = 1) was evaluated. Results of the cell proliferation assay and Real-Time Cell Analyzer assay showed that, compared to wild-type cells, knockout of CALR can confer resistance to JEV-induced death (Fig. 6f, g) .
Furthermore, in the EdU fluorescence assay, the number of fluorescent cells was consistent in CALR knockout cells and wild-type cells, indicating that knocking out CALR genes did not affect normal cell proliferation ( Supplementary Fig. 6 ). These results indicate that CALR is required for JEV replication.
DISCUSSION
Our results highlight the power of CRISPR/Cas9-based screening for functional analyses in pigs, and we present in Figure 7 While genome-scale CRISPR/Cas9 mutagenesis methods obviously facilitate gene functional studies in both cellular and animal models [19] [20] [21] [22] [23] [24] , and the ability to programmably target the entire coding or regulatory genome represents a significant advance over spontaneous or random mutagenesis, genome-scale CRISPR/Cas9 approaches share with classical forward genetic screens the requirement for an assay to enrich for cells exhibiting the phenotype of interest [37] [38] [39] . JEV causes encephalitis in humans and reproductive disorders in pigs, the latter leading to substantial economic losses 10 . In the present study, we developed a series of genome-scale pig CRISPR/Cas9 knockout library (PigGeCKO) resources that facilitate the pooled screening of genes that prevent JEV invasion or replication, thereby inhibiting JEV-induced cell death in porcine cells. Furthermore, we demonstrated how lentiviral delivery of a PigGeCKO library targeting 17,743 protein-coding genes enables positive selection screening for JEV-replication associated host genes.
The first candidate genes examined from this screen are known to function in HSPG metabolism, specifically in the synthesis and modification of heparan sulfate chains in normal cells. The murine homolog of EXT1 protein is known to be localized to the Golgi apparatus 40 , where it binds with EXT2 to form a complex known to modify heparan sulfate 40 . EXT1, EXT2, and EXTL3 together contribute to heparan sulfate chain elongation 41 . In mice, GLCE is an epimerase enzyme required for the biosynthesis of HSPGs, which are composed of a core protein and one or more heparan sulfate glycosaminoglycan chains 42 . The B3GAT3 enzyme catalyzes the formation of glycosaminoglycan-protein linkages by glucuronic acid transfer, which is the final step in the biosynthesis of proteoglycan-linked regions 28 . A previous study identified that knocking out the B3GAT3 gene can significantly inhibit JEV replication 28 , a conclusion that was further confirmed by our genome-scale CRISPR screening and subsequent hypothesis-driven functional analyses. A different study showed that the reduced activity of the B4GALT7 enzyme is associated with a reduced substitution of the proteoglycans decorin and biglycan (both of which have glycosaminoglycan carbohydrate chains) and alterations in heparan sulfate biosynthesis 43 .
Our work strongly supports that HSPG pathway genes can mediate JEV replication in PK-15 cells. Previous studies have shown that the SLC35B2 gene product is located in the microsomal membrane and functions to transport 3'-Phosphoadenosine-5'-phosphosulfate (PAPS) from the cytosol (where it is synthesized)
into the Golgi lumen 43 , whereas the HS6ST1 sulfotransferase enzyme uses PAPS as a substrate for heparan sulfate biosynthesis 44, 45 . Accordingly, our immunofluorescence assays showed that SLC35B2 or HS6ST1 gene knockout in PK-15 cells significantly reduced the extent of sulfurylation modification to heparan sulfate. Therefore, we believe that sulfurylated HSPG serves as an adjunct or adhesion factor during JEV invasion of host cells. It should be noted that our initial screening efforts were based on relatively low MOI JEV challenges of PK-15 mutant cells. Although these experiments succeeded in identifying many host factors involved in JEV replication, future CRISPR screening efforts employing a higher viral challenge dose would potentially reduce false positives and/or identify additional critical host factors in this process.
The second host cellular process implicated in JEV infection involves the EMC3 subunit of the ER membrane protein complex, which is involved in ER-mitochondrial membrane tethering and which is required to facilitate lipid transfer from the ER to the mitochondrial membrane, impacting nearly all aspects of cell physiology 46 . Previous research has found that the ER membrane protein complex is a transmembrane domain insertase, thus loss of EMC causes ER stress and altered protein trafficking 47 . For ZIKV, this complex was required for viral protein accumulation in a cell line harboring a ZIKV replicon 48 . Our CRISPR screen showed that knockout of EMC3 and EMC6 can inhibit JEV-induced cell death. In particular, knockout of the EMC3 gene significantly inhibited the replication of JEV in PK-15 cells. EMC3 and EMC6 are associated with the ERAD pathway, which may participate in the secretory protein quality control processes that guide the removal of aberrantly folded proteins from the ER. Thus, whether the EMC subunits participate in JEV protein biogenesis, misfolding, or direct interaction with JEV particles or JEV-encoded proteins requires further study, for example by using small molecule inhibitors of ER stress.
The final gene we examined via follow-up hypothesis driven studies was CALR, which encodes a multifunctional soluble protein that can bind Ca 2+ ions. Knockout of CALR resulted in a strong JEV resistance phenotype. Proper folding in the endoplasmic reticulum is a prerequisite for the correct localization and function of most secreted and transmembrane proteins 49 , and previous studies have found that CALR and calnexin (CANX) chaperones mediate nascent glycoprotein folding in the endoplasmic reticulum 50, 51 . Thus, we hypothesize that CALR appears to be an essential gene that links JEV replication to downstream cell death pathways, possibly due to calcium homeostasis disequilibrium. For these reasons, CALR knockout cells represent a highly useful new model for studying the relationship between calcium ion homeostasis and JEV infection, additional studies in this area are currently ongoing.
While this study validated six genes selected with follow-up knockout studies and infection assays, our positive selection screening strategy yielded many candidates that may function in JEV infection and as such merit further investigation. We plan to extend the screening described herein to achieve full genome saturation to increase the search scope for host factor genes to further deepen our understanding of the multifaceted and spatiotemporally programmed interactions between JEV and host cells. One limitation of this study is that it did not specifically address issues of potential cell specificity of JEV infection. Although PK-15 cells are susceptible to JEV, this virus primarily infects nerve cells and germ cells 10, 25 . It is also important to note that JEV can infect many different types of cells from highly divergent species, including but not limited to Vero cells, BHK-21 cells, and mouse neuro 2a cells 14 . Thus, testing whether the required factors we identified for JEV infection of PK-15 cells play the same roles in other cell types will require further functional validation.
It is important to consider that some genes may be necessary for normal cell growth, so their knockout may inhibit cell proliferation, which would prevent detection of required genes. JEV is an RNA virus and belongs to the flaviviridae family, and previous studies in humans using CRISPR-based screening strategies have identified many required host genes for cell death induced by DENV, ZIKV, WNV, YFV, and HCV; it is notable that few of these genes appear to overlap [20] [21] [22] [23] [24] . On one hand, the identified genes may differ owing to heterogeneities in the various cell types or species; on the other hand, perhaps the host factors for JEV infection simply differ greatly from other flaviviridae family viruses. Importantly, besides the protein-coding genes examined here, our CRISPR screening additionally identified candidate JEV-replication related lncRNAs (data not shown). Our results highlight the complexity of JEV entry, replication, packaging, and release from host cells, yet also lead the way for a variety of hypothesis-driven basic biological and medical studies to deepen our understanding of this complex process.
MATERIALS and METHODS
Plasmids
The Table 4 ).
All plasmids were confirmed by Sanger sequencing (Tsingke).
Genome-wide porcine sgRNA library design
Three sgRNAs were designed against each protein-coding gene, lncRNA, and miRNA using software of CRISPR-offinder (version 1.2, http://www.biootools.com 26 ). Sequences of protein-coding genes, lncRNA, and miRNA, were found from databases of Ensemble Supplementary Table 4 . 
Generation of mutant cell libraries and screening
A total of~2×10 8 
Knockout of candidate gene in PK-15 cells by CRISPR/Cas9
Individual sgRNA targeting to candidate gene was cloned into the linearized lenti-sgRNA-EGFP and lentivirus were produced as described above. The resulting lentivirus was transduced into PK-15-Cas9 cells. Cells with GFP expression were enriched by FACS and then seeded into 96-well plates to generate single-cell clones. 7 days after transduction, the genotypes of cell colonies were analyzed by extracting genomic DNA (TIANamp Genomic DNA Kit, TIANGEN) and sequencing. All primers for identifying the genotype of cell colonies are listed in Supplementary Table 4 .
T7 endonuclease I cleavage detection assay and Sanger sequencing
All potential off-target sites with high homology in the sgRNAs were predicted using software CRISPR-offinder 26 Supplementary Table 4 .
Illumina sequencing of sgRNAs in the genome-wide library and enriched mutants
The 55 . All primers are listed in Supplementary Table 4 .
Virus plaque assay
Plaque assays were performed on BHK-21 cells. Briefly, BHK-21 cell monolayers at 50% confluence were incubated with serially diluted virus at 37℃ with 5% CO2. 2 hrs after incubation, inoculum was removed, and the cells were overlaid with 50% 2× DMEM, 50% Agarose LMP (Genview), 2% FBS and 1% penicillin streptomycin for 3 days. Cells were fixed with 10% formaldehyde neutral solution overnight at room temperature, then stained with 0.5% crystal violet for 2 hrs at room temperature. Plaques were counted manually and plaque-forming units were calculated. Three independent experiments were performed, with results presented as mean ± SD.
Absolute quantitative real-time PCR
Viral RNA was extracted from cell suspensions using a Viral RNA Extraction Kit Supplementary Table 4 .
Immunofluorescence assay
The expression level of JEV NS3 protein in wild-type or gene knockout PK-15 cells as 
Statistical analysis
Statistical analysis was performed using R programming language. The mean ± SEM was determined for each treatment group in the separated experiments. Two-tailed Student's t-test was used to determine significant differences between treatment and control groups (P ≤ 0.05).
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